New Publications


 Chen G, Xu R, Zhang S, Wang Y, Wang P, Edin ML, Zeldin DC, Wang DW. CYP2J2 overexpression attenuates nonalcoholic fatty liver disease induced by high-fat diet in mice. Am J Physiol Endocrinol Metab. 308, E97-E110, 2015.


BioTarget™ Hypertension ELISA

Our Hypertension/Stroke ELISA (14,15-DHET) Kit has outstanding sensitivity for detection of soluble epoxide hydrolase-and/or UDP-glucuronosyl transferase- dependent hypertensions and development of new hypertension drugs.

Detroit R&D To Be Featured On Discovery Channel "Innovations" TV Show

Beginning on December 1 @ 7:00 AM,
Detroit R&D's research focus on the role of soluble epoxide hydrolase in hypertension and it's BioTarget Hypertension ELISA Kits will be featured on the Discovery Channel Show Innovations

Good Morning Detroit

Enrique Ostrea, Jr., M.D.Professor of Pediatrics, Hutzel Women's Hospital and Children's Hospital of Michigan, Wayne State University, will talk on "Meconium drug testing and persistent pulmonary hypertension of the newborn" May 17, 2017 (Wed) at 9:00 AM (9:00-9:30, coffee mixer and 9:30-10:30, talk and QA


Dietary Supplements

Coming Soon!

Contact Us


Invest in cutting edge technology.

Learn More

About Us

Detroit R&D (DRD) is an NIH SBIR-sponsored company that specializes in the development and manufacture of ELISA, antibodies and assay kits for research, diagnosis and treatment of cardiovascular disease and cancer.

Learn More

Hypertension Biomarkers and Drug Development

We developed and patented Novel Blood and Urine Hypertension Biomarkers and Drug Development Technologies (Patents and References). FDA clearance and CLIA waiver of the validated technologies are in progress. Please contact us for collaboration, licensing-in or investment.

Learn More

No front page content has been created yet.

New Products

Citrate Synthase Enzyme Assay
Mitochondrial Copy Number Assay Kits
GloBrite™ ECL Reagent Kit for Western Blotting


ThermoFisher Scientific

Get Fast, Direct Shipment.

Shop Now